药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ondansetron
Fluindione
The risk or severity of bleeding can be increased when Ceftibuten is combined with Fluindione.
Ondansetron
Ethyl biscoumacetate
The risk or severity of bleeding can be increased when Ceftibuten is combined with Ethyl biscoumacetate.
Ondansetron
(R)-warfarin
The risk or severity of bleeding can be increased when Ceftibuten is combined with (R)-warfarin.
Ondansetron
Coumarin
The risk or severity of bleeding can be increased when Ceftibuten is combined with Coumarin.
Ondansetron
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Ceftibuten is combined with 4-hydroxycoumarin.
Ondansetron
Acenocoumarol
The risk or severity of bleeding can be increased when Ceftibuten is combined with Acenocoumarol.
Ondansetron
Phenprocoumon
The risk or severity of bleeding can be increased when Ceftibuten is combined with Phenprocoumon.
Ondansetron
Potassium
Potassium may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Bromotheophylline
Bromotheophylline may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Epitizide
Epitizide may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Xipamide
Xipamide may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Muzolimine
Muzolimine may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Clopamide
Clopamide may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Fenquizone
Fenquizone may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Clofenamide
Clofenamide may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Clorexolone
Clorexolone may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Cyclopenthiazide
Cyclopenthiazide may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Mebutizide
Mebutizide may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Mefruside
Mefruside may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.
Ondansetron
Meticrane
Meticrane may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy.